IPO ESOP Disclosure India 2026: Outstanding Employee Stock Options, Dilution & DRHP Checklist
IPO ESOP disclosure India is not merely an HR or cap-table exercise. For a company preparing a DRHP, outstanding employee stock options can affect IPO eligibility analysis, fully diluted share capital, earnings-per-share presentation, employee-benefit accounting, pre-issue ownership, and the consistency of multiple offer-document sections. The practical objective is to reconcile every grant, vesting, exercise, lapse and resulting equity share before the offer document is frozen.
As of March 21, 2026, SEBI's consolidated ICDR Regulations provide that an issuer is generally not eligible for an IPO where outstanding convertible securities or other rights entitle a person to receive equity shares. Regulation 5(2), however, expressly carves out qualifying outstanding employee stock options granted under an employee stock option scheme that complies with the Companies Act, 2013 and the relevant accounting framework. This exception does not eliminate the disclosure and reconciliation work; it makes accurate ESOP diligence more important.
IPO ESOP Disclosure India: What the Current SEBI Framework Requires
Part A of Schedule VI to the SEBI ICDR Regulations contains detailed capital-structure disclosures for employee stock option schemes existing before an IPO. For outstanding options, the prescribed disclosure set includes options granted, vested, exercised and lapsed; exercise price; shares arising on exercise; variations in terms; money realised; options in force; specified employee-wise grants; and diluted EPS under the applicable accounting standard. The Schedule also asks for information on pricing methodology and fair-value assumptions in relevant cases.
This matters because the ESOP schedule must agree with the rest of the DRHP. A number appearing in the ESOP table can flow into pre- and post-issue capital, diluted EPS, shareholding disclosures, employee-benefit expense, risk factors and, in some cases, promoter or senior-management disclosures. A clean IPO file therefore starts with one controlled option register rather than parallel spreadsheets maintained by HR, finance, secretarial and legal teams.
What Should Be Reconciled Before the DRHP?
Scheme approvals: board and shareholder resolutions, scheme text, amendments, trust-route documents where applicable, grant letters and compensation-committee records.
Grant population: grant date, employee, number of options, exercise price, vesting schedule, performance conditions and modification history.
Movement bridge: opening options plus grants less exercises, lapses, cancellations or cash settlements equals closing options outstanding.
Vested versus unvested options: the two populations should reconcile to the closing outstanding balance and supporting employee records.
Resultant equity shares: identify the exact conversion or exercise ratio for every scheme or grant class, especially after bonus issues, splits or scheme migrations.
Exercise proceeds: option exercises, share allotments, bank receipts and statutory filings should agree.
Accounting: share-based payment expense and equity balances should reconcile to Ind AS 102 or the applicable accounting framework, while diluted EPS should follow the applicable EPS standard.
Cap table: issued shares, exercised-but-pending allotments where relevant, ESOP pool and outstanding options should be distinguished clearly rather than combined into a single fully diluted number.
Why Outstanding Employee Stock Options Matter for IPO Dilution
The most common management mistake is to look only at issued equity share capital. For IPO planning, finance teams need a second view showing the maximum reasonably determinable equity shares that can arise from outstanding options. That is not the same as assuming every option will necessarily vest or be exercised. It is a scenario view used to understand dilution, cap-table consistency and the consequences of future exercises.
Worked Example: ESOP Dilution Before an IPO
Assume a pre-IPO company has 10,000,000 issued equity shares and 600,000 employee options outstanding on a one-option-for-one-share basis. Of those, 200,000 are vested and 400,000 are unvested. If all 600,000 ultimately become equity shares, the simple fully diluted share count would be 10,600,000. Existing issued shares would then represent about 94.34% of that total, implying potential dilution of about 5.66% relative to the fully diluted share count.
If annual profit were ₹120 million, basic EPS on 10,000,000 issued shares would be ₹12.00. Dividing the same profit mechanically by 10,600,000 gives ₹11.32, but that ₹11.32 is only an illustration of share-count sensitivity. The regulatory diluted-EPS figure must be computed under the applicable accounting standard, including its treatment of potentially dilutive instruments; it should not be replaced by a simplistic fully diluted division.
Recent DRHP Practice Shows Why the Reconciliation Matters
Recent SEBI-filed offer documents demonstrate that ESOP disclosures are often much more detailed than a single option-pool number. One April 2026 DRHP disclosed options outstanding across periods, exercise prices, resultant equity shares and changes to multiple employee stock option plans, including migration of portions of an option pool between schemes. Another updated DRHP disclosed more than 31 million options outstanding translating into more than 113 million resultant equity shares. These are issuer-specific examples, not benchmarks, but they show how scheme terms and conversion ratios can materially change the share-count analysis.
Seven IPO ESOP Red Flags for CFOs and Promoters
The HR option register does not reconcile with statutory allotment records or the finance cap table.
Bonus issues, share splits or restructuring have changed the option-to-share ratio but historical schedules were not restated consistently.
Scheme amendments exist in board minutes but are missing from grant-level records or the data room.
Vested, exercised and allotted are treated as interchangeable stages even though they create different legal and accounting consequences.
The number of resultant shares in the ESOP table differs from the fully diluted capital used elsewhere in the DRHP.
Share-based payment expense is not reconciled to the grant database, valuation inputs and restated financial information.
Management treats the Regulation 5(2) ESOP exception as a waiver from disclosure rather than an eligibility exception accompanied by detailed Schedule VI disclosures.
How a CA-Led IPO Readiness Review Should Test ESOPs
A useful CA-led review does more than collect documents. It creates a controlled bridge from legal approvals to employee-level grants, then from grants to accounting and finally from accounting to the offer document. The reviewer should independently recompute option movements, identify inconsistent conversion ratios, trace exercises to allotments and receipts, test share-based payment accounting, and reconcile fully diluted share counts across the DRHP working files.
The strongest process is to lock a single ESOP master schedule with version control before drafting accelerates. Each subsequent grant, exercise, lapse or scheme amendment should update that schedule and automatically trigger a review of affected DRHP sections. This reduces the risk of different advisers working from different cut-off dates.
Pre-IPO ESOP Data-Room Checklist
All scheme documents and amendments with board/shareholder approvals.
Employee-wise grant register and grant letters.
Vesting, lapse, cancellation, exercise and settlement records.
Exercise-price and option-to-share conversion workings.
Share allotment records, PAS-3 filings and bank evidence for exercises, where applicable.
Share-based payment valuation reports and accounting workings.
Ind AS 102 expense reconciliation and EPS workings.
Fully diluted cap table by scheme and grant class.
Certificate/supporting schedules used for offer-document disclosures.
Cross-reference sheet mapping ESOP numbers to capital structure, restated financials, risk factors and other DRHP sections.
Internal IPO Readiness Links
Start with PGT's IPO Readiness Checklist India 2026 for the broader pre-DRHP workstream.
For cap-table reconciliation, see IPO Capital Structure Cleanup India 2026.
For the separate FMV/tax valuation question, see ESOP Share Valuation India 2026.
FAQs
Can employee stock options remain outstanding when a company files for an IPO?
Qualifying outstanding employee stock options are expressly carved out from the general restriction in Regulation 5(2) of the SEBI ICDR Regulations, subject to the stated compliance conditions. Other outstanding rights and convertible securities require separate analysis and should not be assumed to receive the same treatment.
Does the DRHP need to disclose only vested ESOPs?
No. Schedule VI calls for a broader set of information, including options granted, vested, exercised, lapsed, shares arising on exercise, options in force and other scheme information. The purpose is to show the full employee-option position rather than only immediately exercisable options.
Is fully diluted share capital the same as diluted EPS?
No. A fully diluted cap-table scenario is a share-count and ownership analysis. Diluted EPS is an accounting measure that must be calculated under the applicable accounting standard. They may use related instrument data, but they should not be treated as interchangeable.
Should ESOP valuation and IPO ESOP disclosure be reviewed together?
They should be reconciled but kept conceptually separate. Valuation work supports fair-value, tax or accounting questions; IPO disclosure work focuses on eligibility, scheme terms, option movements, resultant shares, dilution and offer-document consistency.
Practical Takeaway
For an IPO-bound company, the right question is not simply 'how large is our ESOP pool?' The defensible question is whether every option can be traced from approval and grant through vesting, accounting, exercise and resultant equity shares, and whether the same answer appears everywhere in the DRHP. That reconciliation is where finance, secretarial, HR, legal and merchant-banker workstreams meet.
PGT & Associates can support promoters and finance teams with IPO-readiness financial cleanup, ESOP/cap-table reconciliation, restated-financial working support and transaction-focused financial due diligence. The scope should be coordinated with the issuer's merchant banker, legal counsel, statutory auditor and other regulated intermediaries as applicable; no listing or regulatory outcome is guaranteed.
Comments